Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

Seamlessly bridge your LNP discovery journey from RUO to bulk GLP-tox and GMP excipient-grade material.
Explore CGMP Lipid ServicesLipid CL1 is an ionizable cationic trialkyl lipid (pKa = 6.3) that has been used in the formation of lipid nanoparticles (LNPs) for delivering mRNA in vivo.1,2 LNPs containing lipid CL1 and encapsulating mRNA encoding human erythropoietin (EPO) increase blood EPO protein levels in mice.2 LNPs containing lipid CL1 and encapsulating mRNA encoding a reporter protein increase reporter expression in the liver to a greater extent than LNPs containing the ionizable lipids DLin-DMA (Item No. 36701), KC2 (DLin-KC2-DMA; Item No. 34363), MC3 (DLin-MC3-DMA; Item No. 34364), or LP-01 (Item No. 37278) in mice.1 LNPs containing lipid CL1 and encapsulating mRNA encoding influenza A hemagglutinin (HA) increase anti-HA IgG antibody titers to a greater extent than LNPs containing the ionizable cationic lipid SM-102 (Item No. 33474) in a mouse model of HA vaccination.
WARNING This product is not for human or veterinary use.
1. Unsaturated, trialkyl ionizable lipids are versatile lipid-
2. Lipid nanoparticles. (2022).